Replimune Group, Inc. (REPL)

NASDAQ

$13.47

$+0.57

(+4.43%)

Regular Market

Replimune Group, Inc. (REPL) Live Price Chart

Last updated: ⁦2026-09-22 18:56:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Replimune Group, Inc. (REPL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $13.47, with a market capitalisation of $1.23B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.50 to $16.33. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.23B
Open	$12.93
Day's High	$54.85
Day's Low	$1.50
Previous Close	$12.87
Volume	773.65K
Average Volume	4.47M
P/E Ratio	--
52-Week High	$16.33
52-Week Low	$1.50
Dividend Yield	--
Earnings Date	--

Replimune Group, Inc. (REPL) Stock Price Today

Replimune Group, Inc. (REPL) is currently trading at $13.47 as of 2026-09-22 18:55:00, up 4.66% ($0.60) from the previous close of $12.87

During today's regular trading session, REPL has traded between $1.50 and $54.85, with a trading volume of 773.65K shares. The current price is near the lower end of today's range.

Replimune Group, Inc. (REPL) 7-Day Stock Price Change

Over the past seven days, Replimune Group, Inc. (REPL) moved from $12.92 to $13.47, representing a gain of 4.26% ($0.55).

The stock traded between $12.40 and $13.74 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 2.19 million shares, up versus the previous seven-day period, indicating higher trading activity.

REPL 52-Week Price Position

Position in Range: 80.7%

52W Low$1.50

52W High$16.33

REPL is currently trading at $13.47, placing it 80.7% of the way from its 52-week low of $1.50 to its 52-week high of $16.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Replimune Group, Inc. (REPL)?

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Replimune Group, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	465
Exchange	NASDAQ
Company Website	https://www.replimune.com

How to Buy Replimune Group, Inc. (REPL) Stock on MEXC

Eligible investors can buy real shares of Replimune Group, Inc. (REPL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for REPL and Place Your Order

Open the RealStocks trading page and search for REPL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Replimune Group, Inc. (REPL) stock price today?

Replimune Group, Inc. (REPL) is currently trading at $ 13.47, up 4.66% ($0.60) from the previous close of $ 12.87. Intraday prices update in real time during regular trading hours.

2.Is REPL stock going up or down today?

As of 2026-09-22 18:55:00, REPL is trading at $ 13.47, up 4.66% ($0.60) from its previous close of $ 12.87. The stock has traded between $ 1.50 and $ 54.85 during today’s regular session. Past price movements do not guarantee future results.

3.What is REPL pre-market price?

As of 2026-09-22 18:55:00, REPL is trading at $ 12.95 in pre-market trading, up 0.58% ($0.08) from the previous close of $ 12.87. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is REPL after-hours price?

As of 2026-09-22 18:55:00, REPL is trading at $ 12.83 in after-hours trading, down 0.30% ($0.04) from the regular-session close of $ 12.87. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is REPL stock trading now?

REPL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does REPL sit relative to its 52-week high and low?

Over the past 52 weeks, REPL has traded between a low of $ 1.50 and a high of $ 16.33. At $ 13.47, the stock is positioned 80.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Replimune Group, Inc. in?

Replimune Group, Inc. (REPL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Replimune Group, Inc.'s market capitalisation and where is it listed?

Replimune Group, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.23B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is REPL valued in terms of P/E ratio and EPS?

REPL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.15. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Replimune Group, Inc. pay a dividend?

Replimune Group, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.